Type 2 & other diabetes

Interplay between frailty and cardiometabolic disorders: from pathophysiology to clinical implications

Cardiovasc DiabetolPublished Systematic review

Study context

Population
Older adults with frailty and cardiometabolic disorders (diabetes, hypertension, CVD)

Pooled result

As reported in the abstract

  • Documents current knowledge on definitions, epidemiology and pathophysiology of frailty in cardiometabolic disorders and the main clinical implications of their coexistence
  • Discusses evidence-based strategies for assessment, prevention and management, emphasizing an integrated approach

Original publication

Interplay between frailty and cardiometabolic disorders: from pathophysiology to clinical implications. Cardiovasc Diabetol. Published 8 December 2025. doi:10.1186/s12933-025-03022-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.